- $39.46m
- $24.19m
- $27.66m
- 41
- 53
- 56
- 49
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7.39 | 7.56 | 7.58 | 20.5 | 27.7 |
Cost of Revenue | |||||
Gross Profit | 1.76 | 2.6 | 2.51 | 3.96 | 9.65 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 25.1 | 25.3 | 37.5 | 97 | 88.9 |
Operating Profit | -17.7 | -17.7 | -29.9 | -76.5 | -61.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -17.8 | -17.7 | -29.4 | -76.7 | -62.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -17.8 | -17.7 | -29.4 | -76.8 | -62.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -17.8 | -17.7 | -29.4 | -76.8 | -62.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -18.3 | -20.9 | -33.1 | -78.8 | -63.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -15.6 | -9.22 | -5.55 | -4.71 | -2.58 |